BBHC
DRTS icon

Brown Brothers Harriman & Co’s Alpha Tau Medical DRTS Stock Holding History

Brown Brothers Harriman & Co’s Portfolio DRTS Stock Details DRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.8K Buy
+820
New +$5.79K ﹤0.01% 1463

Other funds holding DRTS

HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $130M AUM
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Brown Brothers Harriman & Co's DRTS Position: Q1 2026 in Review

Brown Brothers Harriman & Co opened a new position in Alpha Tau Medical (DRTS) in Q1 2026: 820 shares worth $5.8K. The stake represents ﹤0.01% of the portfolio and ranks #1463 among its holdings.

53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Brown Brothers Harriman & Co held 820 shares of Alpha Tau Medical worth $5.8K as of Q1 2026.
  • Alpha Tau Medical was a new Brown Brothers Harriman & Co position in Q1 2026.
  • Alpha Tau Medical made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q1 2026, its #1463 holding.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q1 2026, filed 14 May 2026.